
PTC Therapeutics Inc
NASDAQ:PTCT

Intrinsic Value
The intrinsic value of one
PTCT
stock under the Base Case scenario is
35.15
USD.
Compared to the current market price of 47.39 USD,
PTC Therapeutics Inc
is
Overvalued by 26%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
PTC Therapeutics Inc
Fundamental Analysis


Revenue & Expenses Breakdown
PTC Therapeutics Inc
Balance Sheet Decomposition
PTC Therapeutics Inc
Current Assets | 1.4B |
Cash & Short-Term Investments | 1.1B |
Receivables | 158.6m |
Other Current Assets | 67.3m |
Non-Current Assets | 339.5m |
PP&E | 117.7m |
Intangibles | 201.1m |
Other Non-Current Assets | 20.7m |
Free Cash Flow Analysis
PTC Therapeutics Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
PTC Therapeutics Inc
Revenue
|
806.8m
USD
|
Cost of Revenue
|
-57.4m
USD
|
Gross Profit
|
749.4m
USD
|
Operating Expenses
|
-891.7m
USD
|
Operating Income
|
-142.3m
USD
|
Other Expenses
|
-221m
USD
|
Net Income
|
-363.3m
USD
|
PTCT Profitability Score
Profitability Due Diligence
PTC Therapeutics Inc's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

Score
PTC Therapeutics Inc's profitability score is 33/100. The higher the profitability score, the more profitable the company is.
PTCT Solvency Score
Solvency Due Diligence
PTC Therapeutics Inc's solvency score is 36/100. The higher the solvency score, the more solvent the company is.

Score
PTC Therapeutics Inc's solvency score is 36/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
PTCT Price Targets Summary
PTC Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
PTCT
is 64.55 USD
with a low forecast of 42.42 USD and a high forecast of 118.65 USD.
Dividends
Current shareholder yield for PTCT is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
PTCT
stock under the Base Case scenario is
35.15
USD.
Compared to the current market price of 47.39 USD,
PTC Therapeutics Inc
is
Overvalued by 26%.